Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Exploratory research results presented at Psych Congress 2026 in New OrleansFull poster presentation can be found on “Publications” section of Company’s websiteSOUTH SAN FRANCISCO, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Vistagen NASDAQ:VTGN, a late clinical-stage biopharmaceutical company lever…